FR2654932B1 - Composition anorexigene. - Google Patents

Composition anorexigene.

Info

Publication number: FR2654932B1
Authority: FR; France
Prior art keywords: anorexigen; composition; anorexigen composition
Prior art date: 1989-11-28
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

FR909014737A

Other languages

English (en)

Other versions

FR2654932A1 (fr

Inventor

Richard J Wurtman

Timothy J Maher

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Indevus Pharmaceuticals Inc

Original Assignee

Interneuron Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-11-28

Filing date

1990-11-26

Publication date

1993-08-13

1990-11-26 Application filed by Interneuron Pharmaceuticals Inc filed Critical Interneuron Pharmaceuticals Inc

1991-05-31 Publication of FR2654932A1 publication Critical patent/FR2654932A1/fr

1993-08-13 Application granted granted Critical

1993-08-13 Publication of FR2654932B1 publication Critical patent/FR2654932B1/fr

2010-11-26 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Obesity (AREA)
Diabetes (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Child & Adolescent Psychology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

FR909014737A 1989-11-28 1990-11-26 Composition anorexigene. Expired - Fee Related FR2654932B1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US07/442,011 US5019594A (en)	1989-11-28	1989-11-28	Method for decreasing appetite

Publications (2)

Publication Number	Publication Date
FR2654932A1 FR2654932A1 (fr)	1991-05-31
FR2654932B1 true FR2654932B1 (fr)	1993-08-13

Family

ID=23755167

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR909014737A Expired - Fee Related FR2654932B1 (fr)	1989-11-28	1990-11-26	Composition anorexigene.

Country Status (9)

Country	Link
US (1)	US5019594A (fr)
JP (1)	JPH03170421A (fr)
KR (1)	KR0173459B1 (fr)
CA (1)	CA2027815A1 (fr)
CH (1)	CH681959A5 (fr)
DE (1)	DE4037708A1 (fr)
FR (1)	FR2654932B1 (fr)
GB (1)	GB2238477B (fr)
IT (1)	IT1247784B (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5096712A (en) *	1990-03-06	1992-03-17	Interneuron Pharmaceuticals, Inc.	Method for enhancing performance so as to improve vigor and decrease fatigue, confusion, tension, and anxiety
US5527788A (en) *	1994-01-18	1996-06-18	Louisiana State Univ. Medical Center Foundation	Method and composition for treating obesity comprising dehydroepiandrosterone (DHEA), or a derivative thereof, and an anorectic agent
FR2746644A1 (fr) *	1996-03-18	1997-10-03	Firion Jackie	Produit parapharmaceutique moderateur d'appetit
CA2260892A1 (fr) *	1996-07-17	1998-01-22	Nicada, Inc.	Coupe-faim
US5795880A (en) *	1996-12-30	1998-08-18	Louisiana State University Medical Center Foundation	Method and composition for treating obesity and related disorders in animals comprising dehydroepiandrosterone (DHEA), or a derivative thereof, and an anorectic agent
US5798101A (en) *	1997-01-22	1998-08-25	Hpf, L.L.C.	Herbal appetite suppressant and weight loss composition
US5900418A (en) *	1997-02-10	1999-05-04	Synapse Pharmaceuticals International, Inc.	Method for treatment of obesity
IL132634A0 (en) *	1997-04-29	2001-03-19	Kenneth Blum Inc	Allelic polygene diagnosis of reward deficiency syndrome and treatment
US6132724A (en) *	1998-04-29	2000-10-17	City Of Hope National Medical Center	Allelic polygene diagnosis of reward deficiency syndrome and treatment
WO2001005356A2 (fr) *	1999-07-20	2001-01-25	Natrol, Inc.	Produit de surveillance de poids a base d'un melange synergique d'extrait de guggul, de sel de phosphate et un stimulant metabolique
US6759437B2 (en) *	1999-10-04	2004-07-06	Martin C. Hinz	Comprehensive pharmacologic therapy for treatment of obesity including cysteine
US6403657B1 (en) *	1999-10-04	2002-06-11	Martin C. Hinz	Comprehensive pharmacologic therapy for treatment of obesity
US6673363B2 (en)	1999-12-16	2004-01-06	Dermatrends, Inc.	Transdermal and topical administration of local anesthetic agents using basic enhancers
US6602912B2 (en)	2000-06-30	2003-08-05	Dermatrends, Inc.	Transdermal administration of phenylpropanolamine
US6719997B2 (en)	2000-06-30	2004-04-13	Dermatrends, Inc.	Transdermal administration of pharmacologically active amines using hydroxide-releasing agents as permeation enhancers
US20030104041A1 (en) *	1999-12-16	2003-06-05	Tsung-Min Hsu	Transdermal and topical administration of drugs using basic permeation enhancers
US7892586B2 (en)	2001-02-22	2011-02-22	Suzanne Jaffe Stillman	Water containing soluble fiber
US7115297B2 (en) *	2000-02-22	2006-10-03	Suzanne Jaffe Stillman	Nutritionally fortified liquid composition with added value delivery systems/elements/additives
US8178150B2 (en)	2000-02-22	2012-05-15	Suzanne Jaffe Stillman	Water containing soluble fiber
US20070117869A1 (en) *	2000-11-01	2007-05-24	Cognition Pharmaceuticals Llc	Methods for treating coginitive impairment and improving cognition
US20030119884A1 (en) *	2000-11-01	2003-06-26	Epstein Mel H.	Methods and compositions for regulating memory consolidation
US7619005B2 (en) *	2000-11-01	2009-11-17	Cognition Pharmaceuticals Llc	Methods for treating cognitive impairment in humans with Multiple Sclerosis
JP2004534724A (ja) *	2000-11-01	2004-11-18	センション，インコーポレイテッド	記憶固化を調節するための方法および組成物
US20050059743A1 (en) *	2000-11-01	2005-03-17	Sention, Inc.	Methods for treating mild cognitive impairment and alzheimer's disease
US20030232890A1 (en) *	2000-11-01	2003-12-18	Sention, Inc.	Methods for treating an impairment in memory consolidation
WO2002036077A2 (fr) *	2000-11-06	2002-05-10	Andrx Pharmaceuticals, Inc.	Preparation decongestionnante et antihistaminique a prise quotidienne unique
US20090311795A1 (en) *	2002-03-21	2009-12-17	Hinz Martin C	Bilateral control of functions traditionally regulated by only serotonin or only dopamine
US20070293571A1 (en) *	2006-06-08	2007-12-20	Hinz Martin C	Adminstration of dopa precursors with sources of dopa to effectuate optimal catecholamine neurotransmitter outcomes
MXPA04009123A (es) *	2002-03-21	2005-09-08	C Hinz Martin	Tecnologia de optimizacion del segmento del sistema de serotonina y catecolamina.
US20040229285A1 (en) *	2003-02-21	2004-11-18	Hinz Martin C.	Serotonin and catecholamine system segment optimization technology
EP1578401A4 (fr) *	2002-04-22	2009-03-25	Rtc Res & Dev Llc	Compositions et methodes pour favoriser la perte de poids, la thermogenese, la diminution de la faim, une masse musculaire maigre, augmenter le metabolisme et amplifier les niveaux energetiques et utilisation en tant que complement alimentaire chez des mammiferes
CA2588087A1 (fr) *	2004-11-15	2006-05-18	Obe Therapy Biotechnology S.A.S.	Methodes de reduction de la graisse corporelle
EP2074081A1 (fr) *	2006-10-17	2009-07-01	Mallinckrodt Inc.	Chlorhydrate de benzphetamine cristallin tres pur et son procede de preparation
US20080221057A1 (en) *	2007-02-16	2008-09-11	Wyeth	Secreted protein ccdc80 regulates adipocyte differentiation
CA2707549A1 (fr)	2007-12-03	2009-06-11	Itzik Harosh	Inhibiteurs boropeptidiques de l'enterokinase et leurs utilisations dans le traitement de l'obesite, de la surcharge ponderale et/ou des maladies associees avec un metabolisme anormal des lipides
WO2014036528A2 (fr)	2012-08-31	2014-03-06	Ixchel Pharma, Llc	Agents utiles pour le traitement de l'obésité, du diabète et de troubles associés
US11344556B2 (en) *	2020-03-03	2022-05-31	Red Mountain Holdings, Llc	Appetite suppressant compositions and methods thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3445518A (en) *	1966-05-06	1969-05-20	Warner Lambert Pharmaceutical	P-acylphenylethylamines
CH543479A (de) *	1970-05-06	1973-10-31	Hoffmann La Roche	Verfahren zur Herstellung von Phenyläthylaminderivaten
US4327112A (en) *	1978-04-24	1982-04-27	Massachusetts Institute Of Technology	Process for increasing blood pressure
US4673689A (en) *	1985-09-25	1987-06-16	Massachusetts Institute Of Technology	Method and composition for enhancing the effect of indirect-acting sympathomimetic amines
US4598094A (en) *	1985-09-25	1986-07-01	Massachusetts Institute Of Technology	Method and composition for enhancing the effect of indirect-acting sympathomimetic amines
US4885312A (en) *	1985-09-25	1989-12-05	Massachusetts Institute Of Technology	Method for enhancing the effect of indirect-acting sympathomimetic amines

1989
- 1989-11-28 US US07/442,011 patent/US5019594A/en not_active Expired - Lifetime
1990
- 1990-10-12 GB GB9022173A patent/GB2238477B/en not_active Expired - Fee Related
- 1990-10-17 CA CA002027815A patent/CA2027815A1/fr not_active Abandoned
- 1990-11-09 JP JP2302834A patent/JPH03170421A/ja active Pending
- 1990-11-21 CH CH3687/90A patent/CH681959A5/fr not_active IP Right Cessation
- 1990-11-22 KR KR1019900018973A patent/KR0173459B1/ko not_active IP Right Cessation
- 1990-11-23 IT IT06792490A patent/IT1247784B/it active IP Right Grant
- 1990-11-26 FR FR909014737A patent/FR2654932B1/fr not_active Expired - Fee Related
- 1990-11-27 DE DE4037708A patent/DE4037708A1/de not_active Withdrawn

Also Published As

Publication number	Publication date
JPH03170421A (ja)	1991-07-24
DE4037708A1 (de)	1991-05-29
KR910009256A (ko)	1991-06-28
US5019594A (en)	1991-05-28
IT9067924A0 (it)	1990-11-23
CA2027815A1 (fr)	1991-05-29
IT9067924A1 (it)	1991-05-29
GB2238477B (en)	1994-04-13
GB9022173D0 (en)	1990-11-28
GB2238477A (en)	1991-06-05
IT1247784B (it)	1994-12-30
KR0173459B1 (ko)	1999-02-01
FR2654932A1 (fr)	1991-05-31
CH681959A5 (fr)	1993-06-30

Publication	Publication Date	Title
FR2654932B1 (fr)	1993-08-13	Composition anorexigene.
DE68907659D1 (de)	1993-08-26	Warmhaertende organosiloxanzusammensetzung.
FI904801A0 (fi)	1990-09-28	Komposition.
DE69020982D1 (de)	1995-08-24	Vulkanisierungsform.
NO901838L (no)	1990-10-29	Emulgerbare pasticidiske faststoff-sammensetninger.
DE68916395D1 (de)	1994-07-28	Zusammensetzung.
FI903713A0 (fi)	1990-07-24	Lokal spironolaktonkomposition.
FI890803A (fi)	1990-08-21	Inmatningssystem foer braennluft i en aotervinningspanna.
FI906418A0 (fi)	1990-12-27	Eldfast komposition.
DE68906193D1 (de)	1993-06-03	Hypersphyxia verursachende zusammensetzung.
DE68903729D1 (de)	1993-01-14	Tertiaere thiolaethoxylat-zusammensetzung.
FI892552A (fi)	1989-11-27	Benzoyl- och ketonperoxidkomposition.
FI890299A0 (fi)	1989-01-20	Form.
FI891419A0 (fi)	1989-03-23	Anordning i en gaengoeppningsanordning foer borrmaskineri.
FI902983A0 (fi)	1990-06-14	Komposition.
MA21961A1 (fr)	1991-04-01	Compositions fumigastriques eppaissies .
DE68916142D1 (de)	1994-07-21	Zusammensetzung.
DE68909455D1 (de)	1993-11-04	Polyaethylen-zusammensetzung.
FI890300A (fi)	1990-07-21	Form.
FI901563A0 (fi)	1990-03-28	Germicidial komposition.
FI891719A0 (fi)	1989-04-11	Roersystem foer luftfoerdelning i pappersmaskin.
DE68908568D1 (de)	1993-09-23	Spironolakton zusammensetzungen.
ATE88637T1 (de)	1993-05-15	Hypersphyxia verursachende zusammensetzung.
FI891188A0 (fi)	1989-03-13	Foerpackning foer komponenter i en roerledning.
FI892215A0 (fi)	1989-05-09	Foerraodsmodul i foerraodsutrymmen foer bostadsanvaendares personliga bruk.

Legal Events

Date	Code	Title	Description
2000-09-01	ST	Notification of lapse